PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1886557

A case study: urea cycle disorder.

M M Gallagher·G T Clancy
View original source ↗Export metadata ↓

Abstract

Early identification of symptoms consistent with a urea cycle disorder is crucial to ensure rapid initiation of therapy which, in turn, promotes the best possible prognosis for the newborn. Acute management may include the technological interventions of exchange transfusion, peritoneal dialysis or hemodialysis, prevention and treatment of seizures, prevention and/or treatment of increased intracranial pressure, and complex nutritional support with amino acids and/or essential enzymes. Long-term nursing management will also include identifying and providing supports for the family, promoting the integration of the infant into the family, and promoting infant growth and development.

Explore related subjects

Amino Acid Metabolism, Inborn ErrorsEducation, Nursing, ContinuingHumansInfant, NewbornMaleOrnithine Carbamoyltransferase Deficiency DiseasePatient Care PlanningPrognosisCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M M Gallagher, G T Clancy. 1991. A case study: urea cycle disorder.. https://pubmed.ncbi.nlm.nih.gov/1886557/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

[Biochemical, clinical and genetic analysis of various aminoacidopathies (non-ketotic hyperglycemia, maple syrup urine disease, histidinemia, tyrosinemia)].

The genetical types were classified according to the clinical findings and biochemical results in cases of 13 newborn/children suffering from various aminoacidopathies. The genetical types were: 3 neonatal and 4 infantile types were found out of 7 non-ketotic disease (MSUD) patient was infantile type with 9.1 per cent keto acid decarboxylase activity in leukocyte homogenate. Among the 3 histidinemic patients 1 was severe neonatal type and 2 cases were chronic types. The 2 treated tyrosinemic children proved to be type III. (chronic with rickets).

Amino Acid Metabolism, Inborn Errors↗
PubMed1992

Metabolic studies in a mouse model of hepatorenal tyrosinemia: absence of perinatal abnormalities.

Radiation induced chromosomal deletions at the albino locus in the mouse, lethal when homozygous, cause abnormalities of expression of several unlinked liver specific genes. Recently, the gene encoding FAH was shown to be included in the deletions. Since in humans FAH mutations cause tyrosinemia type I, deletion homozygous mice were suspected of having tyrosinemia. Studies of plasma amino acids did not confirm this suspicion. Also, succinylacetone levels were normal in fetal and newborn livers of deletion homozygotes. The present evidence, therefore, does not support the assumption that the earlier described ultrastructural and enzyme abnormalities in deletion homozygotes are secondary effects of tyrosinemia caused by the deletion of FAH.

Amino Acid Metabolism, Inborn Errors↗